Sleep benefits remain uncertain: a 28-day chamomile study did not show a clear improvement in how people functioned during the day. The article examines Apigenin in Yu Sleep, drawing on a 2024 review in Frontiers in Nutrition. That review covered human studies, many using chamomile extract rather than Apigenin alone. It described the evidence as promising but limited. In the 28-day study, people took 270 mg of chamomile extract twice daily. Daytime functioning seemed to improve, but the result could have been due to chance. Across the human studies described, daily chamomile extract amounts ranged from 220 to 1,500 mg. Many extracts contained about 1% Apigenin. Those are chamomile amounts, not doses of pure Apigenin. That difference matters. The review could not pin down whether chamomile’s effects came from Apigenin or other ingredients. It also reported that only about 5% to 10% of swallowed Apigenin is absorbed. Yu Sleep lists it in a blend without giving its amount. That leaves no clear dose to compare with the studies. Safety is another gap. The review had no separate safety section. The best dose and safety over longer use remain open questions. Both authors also worked for the company that funded the review. For BioSocial members, this makes product details useful context when comparing notes. A record of the product, listed amount, and dates can sit alongside Sleep Duration and next-day observations. Personal changes can help describe an experience, but cannot prove which ingredient caused it. What changes, if any, have you noticed in your sleep numbers or next-day energy while using Apigenin?